Suomija – Medicinos įranga, farmacijos ir asmens higienos produktai – REQUEST FOR INFORMATION: Syringe, which is suitable for intravitreal injections and storage of anti-VEGF medications

Suomija – Medicinos įranga, farmacijos ir asmens higienos produktai – REQUEST FOR INFORMATION: Syringe, which is suitable for intravitreal injections and storage of anti-VEGF medications

I dalis: Perkančioji organizacija

I.1) Pavadinimas ir adresai:

Oficialus pavadinimas: HUS Group
Adresas: Uutistie 5 (PO Box 441, 00029 HUS)
Miestas: Vantaa
Pašto kodas: 01770
Šalis: Suomija
Asmuo ryšiams:
El-paštas: kilpailutus.aneteho@hus.fi
Interneto adresas (-ai):
Pagrindinis adresas: http://www.hus.fi

II dalis: Objektas

II.1.1) Pavadinimas:

REQUEST FOR INFORMATION: Syringe, which is suitable for intravitreal injections and storage of anti-VEGF medications
Nuorodos numeris: HUS 508-2024

II.1.2) Pagrindinis BVPŽ kodas:

33000000 Medicinos įranga, farmacijos ir asmens higienos produktai

II.1.3) Sutarties tipas:

Kita

II.1.4) Trumpas aprašymas:

With this request for information, HUS launches a market consultation to prepare a procurement. The aim of this prior information notice is to find suppliers operating in this field of business, get information of the solutions available in the market, and inform our plans and requirements for the forthcoming procurement. SUBJECT OF PROCUREMENT The subject of procurement is syringe, which is suitable for intravitreal injections and storage of anti-VEGF medications. We are looking for syringes, which have optimal dosage control. Syringe sizes have to be 0,2 ml - 0,3 ml and it has to have low dead space. In addition, the product is required to have "luer lock" specification, which ensures a tight fit between syringe and needle. Biological stability data is available for aflibercept and faricimab for at least 14 days in the syringes. Caps, injection and filter needles, bubble adapters, bubble adapter holders and vial holders are also available from the supplier. INFORMATION FOR THE PROCEDURE HUS is tentatively planning to publish a call for tenders (estimated timetable February 2025). We ask interested suppliers to provide more information about their selection and brochures and to register for market dialogue by e-mail kilpailutus.aneteho@hus.fi at the latest 17.12.2024 12 p.m. This notice is not a call for tenders. HUS may specify the subject of the procurement in a subsequent contract notice. The requirements for a subsequent procurement and invitation to tender will be determined on the basis of the needs of the contracting entity, with the aim of taking into account the information obtained in the market survey. This notice provides the information currently held by the contracting entity on the procurement to operators on the market. The procurement is in the planning stage and the plans, with their schedules and information, can still be specified and changed. The request for information does not oblige the procurement unit to carry out the actual procurement, but the decision to initiate a possible procurement process is made separately. Neither the request for information nor its replies are binding on either party. Responding to a request for information does not affect the position of the tenderer in the forthcoming tender. The costs associated with responding to a request for information are borne by the respondent, and HUS does not pay compensation for responding to a request for information or participating the procurement procedure.

II.2) Aprašymas:

II.2.1) Kitas (-i) šio pirkimo BVPŽ kodas (-ai):

33000000 Medicinos įranga, farmacijos ir asmens higienos produktai